As manufacturers play an active role in the patients’ healthcare journey, the boundaries between manufacturers and healthcare providers/payers are becoming increasingly blurry.
The post It Is Time For The Life Sciences Industry To Rethink Its Relationship with HIPAA appeared first on MedCity News.
